Transcriptomics Market size is expected to grow at 5.50% throughout the forecast period, reaching nearly US$ 10.97 Bn by 2029.Transcriptomics Market Overview:
Transcriptomics is the study and collection of transcriptomes, and it has a wide range of applications, most notably in molecular genetics. There could be a lot of new product launches in the global transcriptomics industry.To know about the Research Methodology :- Request Free Sample Report
Transcriptomics Market Dynamics:
The growing demand for personalized medicine is the major driving factor for market growth. In the biotechnology business, there is an increase in the number of PCR applications; this aspect is projected to fuel market growth. The transcriptomics market is predicted to develop due to improvements in the field of transcriptomics, such as the widespread usage of RNA-sequencing and the rise in applications of transcriptomics, such as drug discovery. Furthermore, increased financing and grants from various commercial and government entities have boosted industry growth. NanoString Technologies, Inc. announced new technologies to evaluate the immune response in COVID-19 disease research in June 2020. To provide a thorough investigation of the viral infection and immune response, the business created the nCounter Host Response Gene Expression Panel and the COVID-19 Panel Plus spike-in. MI Transcriptome, Caris Life Sciences' newest addition to its complete genomic profiling solution, was launched in February 2020, allowing Whole Transcriptome Sequencing (WTS). NuGEN Technologies, Inc.'s Trio RNA-Seq, for example, is well suited for low abundance transcript applications since it provides a very sensitive whole Transcriptomics solution. However, several RNA sequencing limitations and a scarcity of experienced personnel are projected to limit industry growth. Due to a lack of understanding of concepts and the selection of precise techniques, research and development costs may rise. This can also lengthen the time it takes to complete some studies. The report has profiled twenty-one key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.Transcriptomics Market Segment Analysis:
The Global Transcriptomics Market is segmented on the basis of Technology and Application. Based on Application, the Diagnostics and Disease Profiling segment is expected to hold a dominant market share during the forecast period. In diagnostics and illness analysis, transcriptomics has a wide range of applications. Transcriptome analyses have been widely used to better understand tumour heterogeneity, classify cancers into molecular subtypes, and identify signals that predict treatment response and patient outcomes. Transcriptomics has transitioned in recent years from pure research uses to diagnostics and medical applications. Transcriptomics are important techniques for speeding up disease diagnosis. The global burden of chronic diseases such as cancer and diabetes is continuously increasing, necessitating the development of improved illness and diagnostic technologies. According to a report issued by GLOBOCAN 2020, there were around 19.2 million new cancer cases and 9.95 million cancer deaths reported globally. This rapidly growing patient base is likely to have a positive impact on segmental growth. Various transcriptomics market companies are always working on creating and introducing new instruments and techniques in the field of illnesses and diagnostics. For example, Ambry Genetics (Ambry) launched the transcriptomic test +RNAinsight in October 2022.Transcriptomics Market Regional Insights:
North America is expected to account for significant market share during the forecast period. North America is predicted to develop the fastest during the forecast period, thanks to increased opportunities, rising healthcare spending, and the implementation of favourable government programmes. North America, particularly the United States, is home to the majority of global manufacturers of transcriptomic systems, platforms, equipment, and technologies. Increased investments in transcriptomics and genomics R&D, as well as increased financing for disease pathology research, have contributed to the company's growth. The growing emphasis on sequencing technologies, the development of more advanced biomedical techniques, and the strong presence of important firms in the region are all likely to boost market revenue growth. The report also helps in understanding the Global Transcriptomics Market dynamics, structure by analyzing the market segments and project the Global Transcriptomics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Transcriptomics Market make the report investor’s guide.Transcriptomics Market Scope: Inquire before buying
Global Transcriptomics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US$ 7.54 Bn. Forecast Period 2023 to 2029 CAGR: 5.50% Market Size in 2029: US$ 10.97 Bn. Segments Covered: by Technology Microarray Real-Time Quantitative Polymerase Chain Reaction(Q-PCR) Sequencing Technologies by Application Diagnostics And Disease Profiling Drug Discovery Others Transcriptomics Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Transcriptomics Market Key Players
1. Becton 2. GE Healthcare 3. Roche Diagnostics 4. Agilent Technologies 5. Thermo Fisher Scientific 6. Illumina, Inc. 7. F. Hoffmann-La Roche Ltd 8. Beckman Coulter, Inc 9. BD 10.Biological Industries 11.bioMérieux SA 12.Bio-Rad Laboratories, Inc 13.Cepheid 14.Takara Bio Inc. 15.Cytognomix 16.Edico Genome 17.Siemens AG 18.QIAGEN 19.Merck KGaA 20.Kapa Biosystems 21.Spatial Transcriptomics Frequently Asked Questions: 1. Which region has the largest share in Global Transcriptomics Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Transcriptomics Market? Ans: The Global Transcriptomics Market is growing at a CAGR of 5.50% during forecasting period 2023-2029. 3. What is scope of the Global Transcriptomics market report? Ans: Global Transcriptomics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Transcriptomics market? Ans: The important key players in the Global Transcriptomics Market are – Becton, GE Healthcare, Roche Diagnostics, Agilent Technologies, Thermo Fisher Scientific, Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome, Siemens AG, QIAGEN, Merck KGaA, Kapa Biosystems, and Spatial Transcriptomics. 5. What is the study period of this market? Ans: The Global Transcriptomics Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Transcriptomics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Transcriptomics Market 3.4. Geographical Snapshot of the Transcriptomics Market, By Manufacturer share 4. Global Transcriptomics Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Transcriptomics Market 5. Supply Side and Demand Side Indicators 6. Global Transcriptomics Market Analysis and Forecast, 2022-2029 6.1. Global Transcriptomics Market Size & Y-o-Y Growth Analysis. 7. Global Transcriptomics Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 7.1.1. Microarray 7.1.2. Real-Time Quantitative Polymerase Chain Reaction(Q-PCR) 7.1.3. Sequencing Technologies 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Diagnostics And Disease Profiling 7.2.2. Drug Discovery 7.2.3. Others 8. Global Transcriptomics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Transcriptomics Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 9.1.1. Microarray 9.1.2. Real-Time Quantitative Polymerase Chain Reaction(Q-PCR) 9.1.3. Sequencing Technologies 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1. Diagnostics And Disease Profiling 9.2.2. Drug Discovery 9.2.3. Others 10. North America Transcriptomics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Transcriptomics Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12. Canada Transcriptomics Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13. Mexico Transcriptomics Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14. Europe Transcriptomics Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 15. Europe Transcriptomics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Transcriptomics Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17. France Transcriptomics Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18. Germany Transcriptomics Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19. Italy Transcriptomics Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20. Spain Transcriptomics Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21. Sweden Transcriptomics Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22. CIS Countries Transcriptomics Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23. Rest of Europe Transcriptomics Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24. Asia Pacific Transcriptomics Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 25. Asia Pacific Transcriptomics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Transcriptomics Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27. India Transcriptomics Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28. Japan Transcriptomics Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29. South Korea Transcriptomics Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30. Australia Transcriptomics Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31. ASEAN Transcriptomics Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32. Rest of Asia Pacific Transcriptomics Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33. Middle East Africa Transcriptomics Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 34. Middle East Africa Transcriptomics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Transcriptomics Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36. GCC Countries Transcriptomics Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37. Egypt Transcriptomics Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38. Nigeria Transcriptomics Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39. Rest of ME&A Transcriptomics Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40. South America Transcriptomics Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 41. South America Transcriptomics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Transcriptomics Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43. Argentina Transcriptomics Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44. Rest of South America Transcriptomics Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Transcriptomics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Becton 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. GE Healthcare 45.3.3. Roche Diagnostics 45.3.4. Agilent Technologies 45.3.5. Thermo Fisher Scientific 45.3.6. Illumina, Inc. 45.3.7. F. Hoffmann-La Roche Ltd 45.3.8. Beckman Coulter, Inc 45.3.9. BD 45.3.10. Biological Industries 45.3.11. bioMérieux SA 45.3.12. Bio-Rad Laboratories, Inc 45.3.13. Cepheid 45.3.14. Takara Bio Inc. 45.3.15. Cytognomix 45.3.16. Edico Genome 45.3.17. Siemens AG 45.3.18. QIAGEN 45.3.19. Merck KGaA 45.3.20. Kapa Biosystems 45.3.21. Spatial Transcriptomics 46. Primary Key Insights